Tenders / Buyers / Finland

HUS Group, the joint authority for Helsinki and Uusimaa: public contracts and tenders

HUS Group, the joint authority for Helsinki and Uusimaa awarded 38 public contracts worth €119.8M where a value is stated since 2023-10-31; the medical equipment and pharmaceuticals contract held by MSD Finland Oy ends on 2026-12-31 (end date stated). Source: Arcadium Data, data as of .

Contract awards38
Awarded value (stated)€119.8M
Suppliers named14
Ending in 18 months13
Open calls now1
Calls for tender15
First award2023-10-31
Latest award2026-06-19

Awarded value = the award values the notices state (EUR at the notice date), 24 of 38 awards; framework agreements (a ceiling, not spend) and implausible values are left out.

Buyer

FieldValue
NameHUS Group, the joint authority for Helsinki and Uusimaa
CountryFinland
Buyer typeBody governed by public law
CityHelsinki
SourcesEU TED

Top suppliers

SupplierRegistry numberWebsiteAwardsValue won alone
Gilead Sciences Finland Oy5€5.2M
Novartis Finland Oy5€14.5M
Ascendis Pharma A/S2€1.5M
Biogen Finland Oy2€2.0M
Oy Bristol-Myers Squibb (Finland) Ab2€1.4M
Sanofi Oy2€24.5M
Bio-Rad Finland Oy2164920-4 PRH / YTJ (FI)bio-rad.com1n/a
Thermo Fisher Diagnostics Oy1749528-1 PRH / YTJ (FI)thermoscientific.com1n/a
BeOne Medicines, GmbH, Dutch Branch1€1.0M
Immunocore Ireland Ltd1€3.1M
Janssen-Cilag Oy1€260k
MSD Finland Oy1€500k
Pfizer Oy1€8.0M
Recordati AB1€600k

Suppliers named on HUS Group, the joint authority for Helsinki and Uusimaa's award notices; registry number and website where the supplier is linked to its register entry. Winners that could be a private person are withheld.

Contracts ending in the next 18 months

EndsContractCurrent holderValueEnd date basis
2026-12-31Sotaterseptivalmisteen (Winrevair) hankintaMSD Finland Oy€500kend date stated
2026-12-31Tislelitsumabin (Tevimbra) hankintan/aend date stated
2026-12-31Tislelitsumabin (Tevimbra) hankintaBeOne Medicines, GmbH, Dutch Branch€1.0Mend date stated
2026-12-31Nusinerseenin (Spinraza) hankintaBiogen Finland Oy€1.0Mend date stated
2026-12-31Palopegteriparatidivalmisteen (Yorvipath) hankintaAscendis Pharma A/S€760kend date stated
2026-12-31Onasemnogeeniabeparvoveekki-infuusionesteen (Zolgensma® 2x10exp13 vektorigenomia/ml infuusioneste, liuos) han…Novartis Finland Oy€8.0Mend date stated
2026-12-31Osilodrostaatin (Isturisa 1 mg, 5 mg ja 10 mg) hankinta aikavälille 1.1.2026-31.12.2026n/aend date stated
2026-12-31Palopegteriparatidivalmisteen (Yorvipath) hankintan/aend date stated
2026-12-31Sotaterseptivalmisteen (Winrevair) hankintan/aend date stated
2026-12-31Osilodrostaatin (Isturisa 1 mg, 5 mg ja 10 mg) hankintaRecordati AB€600kend date stated
2027-12-31Tisagenlekleuseelivalmiste (Kymriah) lapsipotilaille tai korkeintaan 25 vuoden ikäisille nuorille aikuispotil…Novartis Finland Oy€2.0Mend date stated
2027-12-31CAR-T-soluterapiavalmisteet hankintakaudelle 1.1.2026 – 31.12.2027Oy Bristol-Myers Squibb (Finland) Ab, Novartis Finland Oy, Gilead Sciences Finland Oy€20.0Mend date stated
2027-12-31Tisagenlekleuseelivalmiste (Kymriah) lapsipotilaille tai korkeintaan 25 vuoden ikäisille nuorille aikuispotil…n/aend date stated

End dates checked against the official notice: 99% right (n=100, 95% CI 94%-100%, 2026-10-26; method).

Award notices of HUS Group, the joint authority for Helsinki and Uusimaa whose contract period ends in the next 18 months: the end date the notice states, else its start or signature date plus the stated duration. 13 contracts; a framework's value is a ceiling and is not shown.

Open calls for tender

DeadlineCall for tenderPublishedEstimated value
2026-11-09MLPA-Based CNV Testing for BRCA1/BRCA22026-10-08n/a

Calls with a deadline of 2026-10-27 or later (not awarded yet).

Spend by sector (CPV divisions)

SectorCPVAwardsAwarded value
Medical equipment and pharmaceuticals3322€115.8M

Award notices with a named winner, by the main CPV code; value = the total the notices state, in EUR at the notice date; framework agreements (a ceiling, not spend) and implausible values are left out.

Recent awards

PublishedContractWinnersValue
2026-05-15Tislelitsumabin (Tevimbra) hankintaBeOne Medicines, GmbH, Dutch Branch€1.0M
2026-03-11Sotaterseptivalmisteen (Winrevair) hankintaMSD Finland Oy€500k
2026-02-09Osilodrostaatin (Isturisa 1 mg, 5 mg ja 10 mg) hankintaRecordati AB€600k
2026-01-29Palopegteriparatidivalmisteen (Yorvipath) hankintaAscendis Pharma A/S€760k
2026-01-28Tisagenlekleuseelivalmiste (Kymriah) lapsipotilaille tai korkeintaan 25 vuoden ikäisille nuorille aikuispotil…Novartis Finland Oy€2.0M
2026-01-28Nusinerseenin (Spinraza) hankintaBiogen Finland Oy€1.0M
2025-11-18CAR-T-soluterapiavalmisteet hankintakaudelle 1.1.2026 – 31.12.2027Oy Bristol-Myers Squibb (Finland) Ab, Novartis Finland Oy, Gilead Sciences Finland Oy€20.0M
2025-08-27Nirsevimabin (Beyfortus 50 mg ja 100 mg injektioneste, liuos, esitäytetty ruisku) hankinta RSV-kaudelle 2025-…Sanofi Oy€10.5M
2025-04-14Tisagenlekleuseeli (Kymriah) lapsipotilaille tai korkeintaan 25 vuoden ikäisille nuorille aikauispotilailleNovartis Finland Oy€4.5M
2025-03-03Palopegteriparatidivalmisteen (Yorvipath) hankintaAscendis Pharma A/S€700k

Follow this buyer free

Get HUS Group, the joint authority for Helsinki and Uusimaa's new calls for tender, awards and contracts ending in a free weekly email (Tender Radar free tier: a saved search for this buyer's name in Finland). The same data is in the REST API and the MCP server.

Sources: EU TED, read through their open-data feeds without logging in. Buyer = contracting authority as named on the notice; notices are grouped by the normalised name and country.

Source: Arcadium Data tenders database, 3,811,022 official public procurement notices from EU TED, UK Find a Tender, UK Contracts Finder and national procurement boards, read through their open-data services (no logins). Winners that could be a private person (sole traders) are withheld; buyers are public bodies. Data as of 2026-10-27.

Questions

How many public contracts has HUS Group, the joint authority for Helsinki and Uusimaa awarded?

HUS Group, the joint authority for Helsinki and Uusimaa published 38 contract award notices between 2023-10-31 and 2026-06-19; the 24 that state a value add up to €119.8M (official notices, as of 2026-10-27).

Who are HUS Group, the joint authority for Helsinki and Uusimaa's biggest suppliers?

By contract awards: Gilead Sciences Finland Oy (5), Novartis Finland Oy (5) and Ascendis Pharma A/S (2) (as of 2026-10-27). Winners that could be a private person are not named.

Which HUS Group, the joint authority for Helsinki and Uusimaa contracts end soon?

13 contracts awarded by HUS Group, the joint authority for Helsinki and Uusimaa end in the next 18 months. The soonest with a named holder is the medical equipment and pharmaceuticals contract held by MSD Finland Oy, ending on 2026-12-31 (end date stated) (as of 2026-10-27).

Does HUS Group, the joint authority for Helsinki and Uusimaa have open tenders now?

Yes: 1 calls for tender from HUS Group, the joint authority for Helsinki and Uusimaa are open today (deadline 2026-10-27 or later) (as of 2026-10-27).

What does HUS Group, the joint authority for Helsinki and Uusimaa buy?

Most of HUS Group, the joint authority for Helsinki and Uusimaa's awards are in Medical equipment and pharmaceuticals (CPV 33) (22) (as of 2026-10-27).

Cite as: Arcadium Data, "HUS Group, the joint authority for Helsinki and Uusimaa tenders and contracts: 38 awards, suppliers, contracts ending", https://arcadiumdata.io/tenders/buyers/hus-group-the-joint-authority-for-helsinki-and-uusimaa-fi/, data as of 2026-10-27.